<p>Lawrence Steinman, Director of Pasithea Therapeutics Corporation, has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-116309), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

KTTA

<p>Lawrence Steinman, Director of Pasithea Therapeutics, has acquired common shares of the company. This information was published by Pasithea Therapeutics via the U.S. SEC's EDGAR system. The news is generated by Public Technologies using AI and is for informational purposes only.</p>

Pasithea Therapeutics Director Lawrence Steinman Reports Acquisition of Common Shares